Skip Navigation LinksHome > July 2013 - Volume 113 - Issue 7 > CE Test 2.5 Managing Irritable Bowel Syndrome
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000431921.70418.ff
Feature Articles

CE Test 2.5 Managing Irritable Bowel Syndrome

Contrada, Emily

Free Access
Continued Education
Back to Top | Article Outline

TEST INSTRUCTIONS

* To take the test online, go to our secure Web site at http://www.nursingcenter.com/ce/ajn .

* To use the form provided in this issue, record your answers in the test answer section of the CE enrollment form below. Each question has only one correct answer. You may make copies of the form.

* Complete the registration information and course evaluation. Mail the completed enrollment form and registration fee to: Lippincott Williams and Wilkins, CE Group, 74 Brick Blvd., Bldg. 4, Suite 206, Brick, NJ 08723. You will receive your certificate in four to six weeks. For faster service, include a fax number and we will fax your certificate within two business days of receiving your enrollment form. You will receive your CE certificate of earned contact hours and an answer key to review your results. There is no minimum passing grade.

* Registration deadline is July 31, 2015.

Back to Top | Article Outline

DISCOUNTS AND CUSTOMER SERVICE

* Send in together two or more tests from any nursing journal published by Lippincott, Williams and Wilkins (LWW), and deduct $0.95 from the price of each test.

* We also offer CE accounts for hospitals and other health care facilities online at www.nursingcenter.com. Call 1-800-787-8985 for details.

Back to Top | Article Outline

PROVIDER ACCREDITATION

LWW, publisher of AJN, will award the number of contact hours indicated for each continuing nursing education activity. LWW is accredited as a provider of continuing nursing education by the Commission on Accreditation of the American Nurses Credentialing Center (ANCC).

These activities are also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for the number of contact hours indicated. LWW is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.

The ANCC's accreditation status of the LWW Department of Continuing Education refers to its continuing nursing educational activities only and does not imply Commission on Accreditation approval or endorsement of any commercial product.

Figure. No caption a...
Image Tools
Back to Top | Article Outline

CE TEST QUESTIONS

GENERAL PURPOSE:

To present information about the presentation, pathophysiology, and diagnosis of irritable bowel syndrome, as well as current pharmacologic and nonpharmacologic approaches to treatment.

Back to Top | Article Outline
LEARNING OBJECTIVES:

After reading this article and taking this test, you will be able to

* explain the prevalence, risk factors, etiology, classification, diagnosis, and clinical presentation of irritable bowel syndrome.

* plan the appropriate interventions for patients who have irritable bowel syndrome.

1. The prevalence of irritable bowel syndrome (IBS) in North America is

a. 5% to 10%.

b. 10% to 15%.

c. 15% to 20%.

d. 20% to 25%.

2. IBS is more common among

a. men.

b. patients who are obese.

c. patients under the age of 50.

d. higher socioeconomic groups.

3. According to the Rome III criteria, a diagnosis of IBS requires that patients who meet symptom criteria have experienced them on at least how many days per month for the past 3 months?

a. 3

b. 5

c. 7

d. 9

4. Which IBS subtype is equally common among both genders?

a. IBS with constipation

b. IBS with diarrhea

c. IBS mixed

d. IBS unsubtyped

5. In addition to gastrointestinal problems, patients who have IBS frequently report

a. anorexia.

b. headaches.

c. joint pain.

d. paresthesias.

6. An abnormal level of which of the following substances is thought to play a role in the etiology of IBS?

a. acetylcholine

b. secretin

c. somatostatin

d. serotonin

7. According to a systematic review, which of the following conditions was four times as prevalent in patients meeting the diagnostic criteria for IBS as in control subjects?

a. celiac disease

b. lactose intolerance

c. pyloric stenosis

d. gastroesophageal reflux disease

8. Colonic imaging is recommended to rule out organic disease in patients with IBS symptoms who have any “alarm” features, one of which is

a. diverticulitis.

b. iron deficiency anemia.

c. cholelithiasis.

d. chronic pancreatitis.

9. Which artificial sweetener tends to exacerbate symptoms of IBS?

a. aspartame

b. sucralose

c. sorbitol

d. saccharin

10. According to the American College of Gastroenterology IBS Task Force, which of these is moderately effective in improving global IBS symptoms?

a. wheat bran

b. psyllium husk

c. corn bran

d. calcium polycarbophil

11. Which of these drugs is relatively safe and effective in treating IBS with constipation by activating chloride channels in the intestine and promoting fluid secretion?

a. polyethylene glycol

b. tegaserod

c. methylcellulose

d. lubiprostone

12. Which of these drugs has been withdrawn from the market because of an increased risk of cardiovascular events?

a. polyethylene glycol

b. tegaserod

c. methylcellulose

d. lubiprostone

13. According to the American College of Gastroenterology IBS Task Force, loperamide may help

a. reduce IBS pain.

b. weaken visceral sensation.

c. improve stool consistency.

d. diminish IBS global symptoms.

14. Which of these drugs is currently approved by the Food and Drug Administration (FDA) for the treatment of travelers’ diarrhea and is under FDA review for use in IBS?

a. rifaximin

b. dicyclomine

c. citalopram

d. pinaverium

15. Although tricyclic antidepressants can help reduce symptoms of IBS, their use for this purpose is limited owing to their tendency to cause

a. weight loss.

b. insomnia.

c. sedation.

d. hypertension.

16. Therapy with which of the following is thought to help diminish IBS symptoms by stimulating the hypothalamus–pituitary system and releasing endorphins and enkephalins?

a. peppermint oil

b. acupuncture

c. hypnotherapy

d. probiotics

17. Therapy with which of the following is thought to help improve digestive and intestinal functioning and possibly immunomodulatory responses?

a. peppermint oil

b. acupuncture

c. hypnotherapy

d. probiotics

18. Therapy with which of the following is thought to help diminish IBS symptoms by exerting an antispasmodic effect on the intestinal smooth muscle?

a. peppermint oil

b. acupuncture

c. hypnotherapy

d. probiotics

© 2013 Lippincott Williams & Wilkins. All rights reserved.

Login